Data / Form D filings / Artelon, Inc.
Artelon, Inc.: Form D filing
Artelon, Inc., a biotechnology company in Marietta, GA, filed a Form D with the SEC in 2023. The latest, on June 2, 2023, reports $20 million sold of a $30 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2150 NW PARKWAY SE, SUITE G, Marietta, GA, 30067
- Phone
- (901) 598-8510
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2023
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1978956
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 2, 2023 | New notice | $30,000,004 | $19,999,998 | $10,000,006 | 1 | May 19, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Greg Banker | Director | |
| Aaron Smith | Executive Officer, Director | |
| Mark Cohen | Director | |
| Jeff Byrne | Executive Officer | |
| Carter Meyer | Director | |
| Kirk Nielsen | Director | |
| Steve Becker | Director | |
| Gary Burbach | Director |
Other biotechnology companies in Georgia that filed recently
- Opus Medical Therapies, LLC $485,089 · Sep 22, 2026
- Airway Therapeutics, Inc. $43.5 million · Sep 9, 2026
- FEMASYS INC $30 million · Aug 20, 2026
Every Form D from the week of May 29, 2023 · All recent filings in Georgia · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Artelon, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.